Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug JK07 shows promise in heart failure trial

NCT ID NCT06369298

Ongoing Disease control Sponsor: Salubris Biotherapeutics Inc Source: ClinicalTrials.gov ↗

First seen May 22, 2026 · Last updated May 22, 2026

Summary

This study tests a new drug called JK07 in 282 adults aged 18-85 with chronic heart failure. The goal is to see if JK07 can safely improve heart function. Participants are divided into two groups based on their heart's pumping ability. The study is double-blind, meaning neither participants nor doctors know who gets the drug or a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site 100

    Cleveland, Ohio, 44195, United States

  • Site 101

    Portland, Oregon, 97239, United States

  • Site 102

    Stanford, California, 94305, United States

  • Site 103

    Houston, Texas, 77030, United States

  • Site 104

    Covington, Louisiana, 70433, United States

  • Site 105

    St Louis, Missouri, 63136, United States

  • Site 106

    St Louis, Missouri, 63110, United States

  • Site 107

    Rochester, Minnesota, 55905, United States

  • Site 109

    Cary, North Carolina, 27518, United States

  • Site 110

    Dallas, Texas, 75235, United States

  • Site 111

    Phoenix, Arizona, 85016, United States

  • Site 112

    Indianapolis, Indiana, 46250, United States

  • Site 113

    Torrance, California, 90502, United States

  • Site 114

    Hialeah, Florida, 33016, United States

  • Site 115

    Dallas, Texas, 75246, United States

  • Site 116

    Pasadena, California, 91105, United States

  • Site 117

    Cincinnati, Ohio, 45219, United States

  • Site 118

    Baltimore, Maryland, 21201, United States

  • Site 119

    Boston, Massachusetts, 02114, United States

  • Site 121

    Alexander City, Alabama, 35010, United States

  • Site 122

    Bloomfield Hills, Michigan, 48304, United States

  • Site 123

    Falls Church, Virginia, 22042, United States

  • Site 126

    Norfolk, Virginia, 23507, United States

  • Site 127

    Little Rock, Arkansas, 72205, United States

  • Site 128

    Huntington Beach, California, 92648, United States

  • Site 129

    Santa Maria, California, 93454, United States

  • Site 130

    Birmingham, Alabama, 35211, United States

  • Site 133

    Vista, California, 92081, United States

  • Site 135

    Oklahoma City, Oklahoma, 73135, United States

  • Site 136

    Atlanta, Georgia, 30343, United States

  • Site 137

    Fort Wayne, Indiana, 46804, United States

  • Site 138

    Huntsville, Alabama, 35801, United States

  • Site 139

    Birmingham, Alabama, 35294, United States

  • Site 140

    Charlotte, North Carolina, 28204, United States

  • Site 143

    Boise, Idaho, 83712, United States

  • Site 144

    Brick, New Jersey, 08724, United States

  • Site 145

    Durham, North Carolina, 27710, United States

  • Site 148

    Arlington, Virginia, 22205, United States

  • Site 149

    Tomball, Texas, 77375, United States

  • Site 150

    Farmington Hills, Michigan, 48334, United States

  • Site 152

    Asheville, North Carolina, 28803, United States

  • Site 153

    Valhalla, New York, 10595, United States

  • Site 154

    Park Ridge, Illinois, 60068, United States

  • Site 155

    York, Pennsylvania, 17403, United States

  • Site 156

    Ponce, 00717, Puerto Rico

  • Site 157

    Los Angeles, California, 90033, United States

  • Site 158

    Orange, California, 92868, United States

  • Site 159

    Naples, Florida, 34104, United States

  • Site 160

    Chicago, Illinois, 60611, United States

  • Site 161

    Coral Gables, Florida, 33134, United States

  • Site 162

    Miami Lakes, Florida, 33014, United States

  • Site 163

    Vienna, Virginia, 22182, United States

  • Site 200

    Chicoutimi, Quebec, G7H 7K9, Canada

  • Site 201

    Trois-Rivières, Quebec, G9A 4P3, Canada

  • Site 202

    Winnepeg, Manitoba, R2H2A6, Canada

  • Site 203

    Brampton, Ontario, L6Z 4N5, Canada

  • Site 300

    Beijing, 100037, China

  • Site 301

    Chengdu, Sichuan, 610041, China

  • Site 303

    Nanjing, Jiangsu, 210009, China

  • Site 304

    Chongqing, 404000, China

  • Site 305

    Changsha, Hunan, 410005, China

  • Site 306

    Jining, Shandong, 272100, China

Conditions

Explore the condition pages connected to this study.

HEART FAILURE WITH PRESERVED EJECTION FRACTION HEART FAILURE WITH REDUCED EJECTION FRACTION